Ashwath Jayagopal is Chief Scientific & Dev. Ofc. of Ocuphire Pharma, Inc.. Currently has a direct ownership of 125,807 shares of OCUP, which is worth approximately $123,290. The most recent transaction as insider was on Mar 13, 2025, when has been sold 52,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
60.26% 3M change
67.74% 12M change
Total Value Held $123,290

Ashwath Jayagopal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2025
BUY
Grant, award, or other acquisition
-
52,500 Added 29.44%
125,807 Common Stock
Feb 13 2025
SELL
Payment of exercise price or tax liability
$5,971 $1.15 p/Share
5,193 Reduced 6.62%
73,307 Common Stock
May 22 2024
BUY
Open market or private purchase
$6,160 $1.76 p/Share
3,500 Added 4.27%
78,500 Common Stock
Feb 12 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock
AJ

Ashwath Jayagopal

Chief Scientific & Dev. Ofc.
Farmington Hills, MI

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP